Surprise! PM and BAT condemn ANVISA decision to keep e-cigarettes out of Brazil

Philip Morris and BAT both issued statements condemning ANVISA’s decision to maintain and strengthen e-cigarette regulations to keep the products (and other ENDS products) out of Brazil. Not surprisingly, they use the same generic arguments Big Tobacco uses against almost all regulations. The reality is that, as I noted in my post congratulating ANVISA, whileContinue reading “Surprise! PM and BAT condemn ANVISA decision to keep e-cigarettes out of Brazil”

Brazil strengthens its ban on ENDS, including e-cigarettes and heated tobacco products

On Friday, April 19, 2024, the board of ANVISA, the Brazilian Health Regulatory Agency strengthened its already-strong ban on electronic nicotine systems (ENDS), which includes e-cigarettes and heated tobacco products. In stark contrast to the US Biden Administration, which just caved to industry pressure and blocked the FDA’s well-conceived ban on menthol cigarettes and flavoredContinue reading “Brazil strengthens its ban on ENDS, including e-cigarettes and heated tobacco products”

Why does the Royal College of Physicians report on ecigs and harm reduction minimize knowledge of the adverse effects of nicotine beyond addiction?

E-cigarettes and Harm Reduction: An Evidence Review, the latest in a series of reports it has published since 2007 endorsing e-cigarettes for harm reduction.  In this report, the RCP minimizes the adverse health effects of nicotine (beyond addiction), concluding that “There is little evidence of a long-term harmful physiological effect of nicotine that is notContinue reading “Why does the Royal College of Physicians report on ecigs and harm reduction minimize knowledge of the adverse effects of nicotine beyond addiction?”

Why is the Royal College of Physicians concluding the ecigs help smokers quit when a large body of evidence shows that, as consumer products, they don’t?

On April 18, 2024 the UK Royal College of Physicians published E-cigarettes and Harm Reduction: An Evidence Review, the latest in a series of reports it has published since 2007 endorsing e-cigarettes for harm reduction.  In this report, the RCP recommends that “e-cigarettes should be promoted as an effective means of helping people who smokeContinue reading “Why is the Royal College of Physicians concluding the ecigs help smokers quit when a large body of evidence shows that, as consumer products, they don’t?”

Why is the Royal College of Physicians concluding e-cigs reduce harm while ignoring the substantial associations between e-cigs and actual disease?

On April 18, 2024 the UK Royal College of Physicians published E-cigarettes and Harm Reduction: An Evidence Review, the latest in a series of reports it has published since 2007 endorsing e-cigarettes for harm reduction.  The report covers a wide range of topics, including assessing the health risks of e-cigarettes, the central question on whetherContinue reading “Why is the Royal College of Physicians concluding e-cigs reduce harm while ignoring the substantial associations between e-cigs and actual disease?”

Tobacco industry denormalization supports stronger tobacco control policies

Tobacco industry denormalization — the strategy of educating people about the predatory behavior of the tobacco industry — is used in many high income states and countries. Now, Roengrudee Patanavanich and I have published “Awareness of tobacco industry tactics among tobacco control communities in Thailand and its association with attitudes towards tobacco industry and perceptionsContinue reading “Tobacco industry denormalization supports stronger tobacco control policies”

Why is the FDA still pushing e-cigs as lower risk based on ancient evidence?

Today (April 16, 2024) the FDA released a new web page on The Relative Risks of Tobacco Products that irresponsibly promotes e-cigarettes as a lower risk alternative to cigarettes. This recommendation is based on the 2018 National Academy of Sciences, Engineering and Medicine report on e-cigarettes that concluded that e-cigarettes reduce exposure to some toxicContinue reading “Why is the FDA still pushing e-cigs as lower risk based on ancient evidence?”

What you need to know about secondhand smoke in multiunit housing

Jim Repace, who did the first quantitative risk assessment of secondhand smoke and lung cancer way back in 1980 and helped launch the clean indoor air movement, just published “Secondhand smoke infiltration in multiunit housing: Health effects and nicotine levels” in Indoor Environments. This paper is a combination literature review and summary of data heContinue reading “What you need to know about secondhand smoke in multiunit housing”

More people are stopping smoking since advent of fourth gen e-cigs. Less disease? Probably not.

Karin Kasza and colleagues new well-done study, “Divergence in Cigarette Discontinuation Rates by Use of Electronic Nicotine Delivery Systems (ENDS): Longitudinal Findings From the United States PATH Study Waves 1-6,” uses the large national PATH study to see if there were differences in real-world trends of adults stopping smoking before and after fourth generation e-cigarettesContinue reading “More people are stopping smoking since advent of fourth gen e-cigs. Less disease? Probably not.”

Heated tobacco products damage human lung function as much as cigarettes

Philip Morris has aggressively promoted its heated tobacco product (HTP) IQOS all over the world as a safer alternative to smoking cigarettes based on the fact that IQOS delivers lower levels of some combustion products than cigarettes. IQOS is the most populat HTP in Japan, and other tobacco companies make similar claims for their HTP.Continue reading “Heated tobacco products damage human lung function as much as cigarettes”